[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

Lets start with the definition GB is now only…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in Northern Ireland (NI) need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

For Northern Irish Pharmacies FMD requirements have not changed and they must continue to verify and decommission their “2D” barcoded packs…

Data Collecting Wearable Devices are helping GPs diagnose and track patient symptoms.

by Jackie (née Heneghan) Peck | Dec 22, 2020 | Blog

On line GP consultations are here to stay for a while and the diagnosis of certain conditions are being aided more and more by wearable devices. Many devices now not only measure (for example) heart rates, they can also track and alert of any irregularities in what...

Updates to the Human Medicines Regulations 2012 to help with Covid 19 Vaccine Temporary Approval

by Jackie (née Heneghan) Peck | Dec 21, 2020 | Uncategorized

In October the  Human Medicines Regulations 2012 were updated to allow the MHRA to grant temporary authorisation of  specific batches of the Pfizer/BioNTech Covid-19 vaccine without needing to wait for EMA approval. The approval is a temporary one which will...

Patient Compliance and Augmented Reality “AR”

by Jackie (née Heneghan) Peck | Dec 20, 2020 | Blog

Augmented Reality is being used as a tool to aid patient compliance. Smart phones, apps, cameras  and tablets help to improve patient information and confidence with their medicines. Silver surfers are much more tech savvy.
« Older Entries
Next Entries »

Recent Posts

  • FDA Warning Letters
  • Emerging issues – Communique from the GPhC
  • New MHRA/NICE Collaboration

Upcoming Courses

  • RP Forum – GxP Certificates for Customers and Supplier Qualification on 9 September 2025 10:00 am
  • Introduction to Good Distribution Practice Online Training on 10 September 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 16 September 2025
  • GDP Audit Online Training on 1 October 2025 10:00 am
  • Licence Holder Training on 14 October 2025 10:00 am

MHRA Alerts & Recalls

Field Safety Notices: 11 to 15 August 2025
19 August 2025
Class 4 Medicines Defect Notification: Levetiracetam Accord 100mg/ml oral solution, Accord Healthcare Limited, UK, EL(25)A/40
14 August 2025
Field Safety Notices: 4 to 8 August 2025
12 August 2025
Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd, EL(25)A/39
7 August 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow